Compare ISA Pharmaceuticals vs United Biomedical
Customers evaluate the quality of ISA Pharmaceuticals's products using the following success metrics.
Overview
ISA Pharmaceuticals is 20 yrs old and is based in Netherlands.
ISA Pharmaceuticals develops treatments for various cancers and infectious diseases. It focuses on the development of synthetic peptide vaccines that boost the immune system to recognize specific peptides associated with specific types of cancer and subsequently destroy the tumor cells. The company was founded in 2004 and is based in Oestgeest, Netherlands.
United Biomedical is based in United States
United Biomedical operates as a biopharmaceutical company. The Company develops immunotherapeutics and vaccines for chronic and infectious diseases.
Demo Video
Leadership
Gerben Moolhuizen (Chief Executive Officer)
Lou Reese (Chief Executive Officer)
Funding
Investors
Cancer Focus Fund, Regeneron Pharmaceuticals
BOLD Capital Partners, Prime Movers Lab
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because ISA Pharmaceuticals has not claimed their profile.
Work for ISA Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for ISA Pharmaceuticals?
Claim your profile now.
Information not available because United Biomedical has not claimed their profile.
Work for United Biomedical? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for United Biomedical?
Claim your profile now.